Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_assertion type Assertion NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_head.
- NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_assertion description "[In patients with endometrial carcinoma who did not receive radiotherapy or chemotherapy before surgery, the presence of decreased levels of pRb2/p130 in tumor cells is associated with a significantly increased risk of recurrence and death of disease, independent of tumor stage and ploidy status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_provenance.
- NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_assertion evidence source_evidence_literature NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_provenance.
- NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_assertion SIO_000772 9508194 NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_provenance.
- NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_assertion wasDerivedFrom befree-20150227 NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_provenance.
- NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_assertion wasGeneratedBy ECO_0000203 NP667713.RALtZClCP1ccGzK6tLH-GHamw1CTBdxvhT0LW6D-W_I3I130_provenance.